How much do stem cell count and concentration really matter for outcomes?

A common question patients ask about stem cell therapy is: 'does more cells always mean better results?' The academic answer is not that simple, because cell count is just one of several variables affecting treatment efficacy. Equally important variables include cell quality and viability at the moment of injection, plus the site and method of delivery.

Cell concentration refers to the number of cells per unit volume of the solution injected, which is different from the total cell count. Clinics that harvest cells fresh without culturing typically emphasise high concentration — using centrifugation to gather as many naturally occurring cells as possible from the sample, rather than multiplying cell numbers through weeks of laboratory culture.

By comparison, culturing can theoretically produce far more cells, since they keep dividing in the lab over several weeks before injection. But that process has its own considerations — contamination risk during culture, possible property changes after many division cycles (cellular senescence), and a longer wait for results, which can be inconvenient for patients travelling from abroad on a limited schedule.

Cheongdam Cell Clinic states it chose the non-cultured route because freshly extracted, immediately injected cells carry a lower contamination risk and let patients complete the entire treatment within a single half-day: harvest bone marrow, centrifuge to concentrate the cells, then inject back into the patient according to the chosen programme.

Several factors influence the cell count and quality obtained each time: patient age (older patients generally have fewer stem cells in their marrow than younger ones), baseline health, how much marrow can be harvested in a single aspiration, and the medical team's skill in extraction and centrifugation. These factors mean outcomes can vary between patients even when the same procedure is performed.

Interested patients should ask providers directly whether cell counts are checked before injection, and whether there is a minimum threshold considered adequate for treatment. These questions help patients gauge the transparency of the process, even though clinics may not publish exact figures publicly, since that data is specific to each individual case.

One thing to watch for is marketing that emphasises a cell number in isolation, with no context — for example, citing a very high figure without specifying the measurement method or reference standard. Patients should treat cell count as just one of several decision factors, alongside clinic reputation, physician experience and overall process transparency.

In summary, cell concentration and count are biologically meaningful factors, but they should not be viewed in isolation. Patients considering Cheongdam Cell Clinic or any other provider should ask for full details on the extraction process, injection method and post-treatment follow-up, rather than deciding on cell count alone.